Skip to content

Drug interactions

Clarithromycin + Tisotumab vedotin

Severity: Moderate

Clarithromycin and Tisotumab vedotin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The cytotoxic payload MMAE from tisotumab vedotin is a CYP3A4 substrate. A strong inhibitor like clarithromycin may raise MMAE exposure and increase toxicity, including neuropathy, neutropenia and ocular effects.

What this interaction means in plain words

Clarithromycin and Tisotumab vedotin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Clarithromycin belongs to Anti Bacterial; Tisotumab vedotin belongs to Oncology.

Evidence level: Moderate

Why it happens

Clarithromycin inhibits CYP3A4 metabolism of MMAE.

What to do

Consider a non-CYP3A4-inhibiting antibiotic. If combined, monitor for adverse reactions of tisotumab vedotin.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Clarithromycin and Tisotumab vedotin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Clarithromycin with Tisotumab vedotin?

MediHelp rates the interaction as moderate. Clarithromycin and Tisotumab vedotin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. The cytotoxic payload MMAE from tisotumab vedotin is a CYP3A4 substrate. A strong inhibitor like clarithromycin may raise MMAE exposure and increase toxicity, including neuropathy, neutropenia and ocular effects.

How serious is the interaction between Clarithromycin and Tisotumab vedotin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider a non-CYP3A4-inhibiting antibiotic. If combined, monitor for adverse reactions of tisotumab vedotin.

What other medicines interact with Clarithromycin?

MediHelp also lists interactions of Clarithromycin with, for example, Astemizole, Avanafil, Cisapride. The full list is on the Clarithromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in